* Zynex Inc ZYXI.OQ reported quarterly adjusted earnings
of 4
cents per share for the quarter ended in June, lower than the
same quarter last year, when the company reported EPS of 9
cents. The mean expectation of three analysts for the quarter
was for earnings of 8 cents per share. Wall Street expected
results to range from 7 cents to 8 cents per share.
* Revenue rose 11% to $49.88 million from a year ago;
analysts
expected $52.09 million.
* Zynex Inc's reported EPS for the quarter was 4 cents.
* The company reported quarterly net income of $1.22
million.
* Zynex Inc shares had risen by 8.2% this quarter and
lost 7.4% so
far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 9.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Zynex Inc is
$18.75
This summary was machine generated from LSEG data July 25 at
09:52 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 0.08 0.04 Missed
Mar. 31 2024 0.03 0.00 Missed
Dec. 31 2023 0.17 0.21 Beat
Sep. 30 2023 0.09 0.10 Beat